Sign in

CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company

ENDONOVO THERAPEUTICS, INC.

Sign in to watch
Ticker
ENDV
Exchange
OTC
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452552528
Phone
(800) 489-4774
Business address
6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
Former names
Hanover Portfolio Acquisitions, Inc.
  1. 4 Open-market buy CEO bought 81,500 shares at an average $0.01 ($1,037)
  2. 4 Open-market buy CEO bought 160,774 shares at an average $0.01 ($1,904)
  3. 10-Q Report Quarterly Report
  4. 4 Open-market buy CEO bought 255,000 shares at an average $0.01 ($2,859)
  5. 4 Open-market buy CEO bought 179,000 shares at an average $0.01 ($1,974)
  6. 4 Open-market buy CEO bought 40,000 shares at an average $0.01 ($596)
  7. 4/A Open-market buy CEO bought 57,000 shares at an average $0.01 ($672)
  8. 4 Open-market buy CEO bought 55,000 shares at an average $0.01 ($646)
  9. 4 Open-market buy CEO bought 48,000 shares at an average $0.01 ($676)
  10. 10-K Report Annual Report
  11. 4 Open-market buy CEO bought 13,500 shares at an average $0.02 ($230)
  12. 4 Open-market buy President bought 5,000 shares at $0.02 ($85)
  13. 4 Open-market buy CEO bought 36,000 shares at an average $0.02 ($632)
  14. NT 10-K Other NT 10-K
  15. 4 Open-market buy CEO bought 54,000 shares at an average $0.02 ($983)
  16. 4 Open-market buy President bought 22,000 shares at an average $0.02 ($414)
  17. 4 Open-market buy President bought 2,000 shares at $0.02 ($42)
  18. 4 Open-market buy CEO bought 43,000 shares at an average $0.02 ($827)
  19. 4 Open-market buy CEO bought 54,500 shares at an average $0.02 ($1,099)
  20. 4 Open-market buy CEO bought 21,000 shares at an average $0.02 ($413)

Page 6 of 26 · 502 filings